Sustained virological response: a milestone in the treatment of chronic hepatitis C. - Test2 - elhamkhani - TriplyDB

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q36841325

about

Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C A comprehensive long-term prognosis of chronic hepatitis C patients with antiviral therapy: a meta-analysis of studies from 2008 to 2014 Drug Pricing Evolution in Hepatitis C Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12.Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection.Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection.GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?Beclabuvir for the treatment of hepatitis C.Asunaprevir for hepatitis C: a safety evaluation.Asunaprevir (BMS-650032) for the treatment of hepatitis C virus.An insight into the molecular characteristics of hepatitis C virus for clinicians.Discontinued drugs in 2012 - 2013: hepatitis C virus infection.The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C.Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection.Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt.Hepatitis C, stigma and cure.Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.

P2860

Q26781789-68FE1C63-C05B-48F2-9BF2-56261C276DFC Q28081137-D514A8C0-8ECC-4C0E-95AC-8A5E987C28EF Q28550311-BA9079A3-84DB-49F5-B593-085F72169DAD Q30244361-97F4BE19-2D88-4516-BA4D-35CEA4F71C3E Q30374727-201684A4-144E-4AC1-A679-5AA30DADBC3B Q30399476-CB0DF172-07B9-466D-BC29-6C4A89A12369 Q34411907-90619FD5-CFDE-407C-B2F7-5017F48CE852 Q34420891-4547A4F6-3691-430E-9C17-8AE94B9C7AB3 Q34424151-FE97770B-0736-4786-918F-86CD0A65C150 Q35164782-991FE790-31F4-4A8E-B36A-8F373C48AB4F Q36145716-DFF05F65-2A19-4BF3-B41D-3A664EFFB1F0 Q36848958-736813F0-28C6-4FF7-9F3B-029B30D4C5C1 Q38193198-8803BF11-CBAD-4979-AD7A-F4881BBEC7E6 Q38212793-51443248-82C2-495D-9D60-1E923F5B810C Q38233860-B86CFA6D-FEEC-4387-971A-BA7AAC473F69 Q38235178-84D3A37F-2CCD-4345-93F9-B4926BC3280F Q38237281-A06C2BF2-4936-4C53-9D8D-A051DFF91F56 Q38314738-8CD84C13-8879-422A-872E-B39613582991 Q38544196-554A575D-7779-4DCD-B498-B4DFD1E1BDBB Q38578458-EBAA00D5-B37D-496D-9BFC-BD3BF6A5EC01 Q38594613-AC5035D1-6A94-4FE4-AEBB-E8BB7D7A5245 Q38825949-24FA3371-0B65-40CC-8DD0-5A6C04950DA9 Q39100351-3E25B381-FF13-458C-AE36-501B4578768D Q40326326-BBD841E6-ED03-499F-B324-D0D430F96730 Q40677384-849CE941-7D93-47C8-AF48-F0CDC51CAF4F Q41923679-983A130B-B72D-478B-9162-A074F2AD01BF Q42928878-78A3C4A2-34BD-43BB-A3D5-CE425D547BAC Q55348708-2E1F81FD-ACEA-4CFD-A2E6-D02AFB9C58F3

P2860

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q36841325

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

@en

type

label

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

@en

prefLabel

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

@en

P1433

Q36841325-2E64B7E6-D6D6-4DE5-985A-141E25FD825F

P1476

Q36841325-A27C5EDC-9347-49F4-AA7C-14459605D06F

P2093

Q36841325-009B33F6-DFD7-478D-A002-49A12956FF69

Q36841325-01EE894B-E517-4382-AE03-25DEF5734999

Q36841325-10B296CF-29C5-4FE8-A90A-F56A502A76FD

Q36841325-7DA9B4FC-E699-454A-A925-62DC5F07C6B8

Q36841325-8C5650CD-CD7E-474D-A448-9053BBB8FB35

Q36841325-ABE5409B-CF62-4015-9BA3-CC937F1A8375

Q36841325-FA42D7EF-15B6-407B-9C7E-EB100E8C2BD4

P2860

Q36841325-035F0D42-6B91-438C-BB62-C1DA0721DA1F

Q36841325-0A5128EF-60D1-406F-8DB0-03A70C815AEC

Q36841325-0BA977E9-0399-4C8A-9539-2A9FA454068B

Q36841325-0D607194-8BAB-4B3D-905A-F305D006AC65

Q36841325-17DCAC70-FCE2-43D5-A98E-8626D84CC73C

Q36841325-21A9E3B3-316A-428A-B878-B745A7741D89

Q36841325-234BA4B4-4BAC-4DC0-B395-30E18BF6A706

Q36841325-25490417-38AD-4ABD-B533-604461B82186

Q36841325-258ACA6E-3D6A-4492-8144-DAC2373CD61E

Q36841325-30357BFB-13AA-4529-B5AF-C68B68739BA6

P304

Q36841325-03B20F6E-8B64-4917-8BB9-9D827405B3AA

P31

Q36841325-9B3E9B32-89CD-49F3-A73C-69E9090E626A

P356

Q36841325-FFFDAE2E-D3D0-4357-8F87-5DD4870BB201

P407

Q36841325-6F98841F-FDAC-4336-B65E-5253DE902460

P433

Q36841325-99ED4794-5B46-4012-B469-79330887B1B5

P478

Q36841325-12C31EA2-9CF8-454E-90F3-A38C53C23686

P50

Q36841325-5FFA22CF-3192-4D17-ACC6-E115FF3629F7

Q36841325-A764D0A3-8B4F-4798-B24C-F3C60A0C6A8D

Q36841325-F6A960B1-45DE-4A56-96A2-105E160B1389

P577

Q36841325-B107BC41-61C2-4708-BD8A-413BA99CF7B3

P5875

Q36841325-656FEB8F-0B4B-491E-B2D5-67CB0FAB314F

P698

Q36841325-8A5338DE-D68B-4B60-9E55-B8D652737699

P921

Q36841325-8C0831F7-8175-424E-B70C-61640DDAD021

P932

Q36841325-769E3202-7217-46AA-AE6A-0A5DB6D0044E

P356

WJG.V19.I18.2793

P1433

World Journal of Gastroenterology

P1476

Sustained virological response: a milestone in the treatment of chronic hepatitis C

@en

P2093

Filomena Morisco

http://www.w3.org/2001/XMLSchema#string

Francesco Auriemma

http://www.w3.org/2001/XMLSchema#string

Ilaria Loperto

http://www.w3.org/2001/XMLSchema#string

Laura Donnarumma

http://www.w3.org/2001/XMLSchema#string

Laura Gaeta

http://www.w3.org/2001/XMLSchema#string

Nicola Caporaso

http://www.w3.org/2001/XMLSchema#string

Rocco Granata

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Histological grading and staging of chronic hepatitis

Prognosis of hepatocellular carcinoma: the BCLC staging classification

The global burden of hepatitis C

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy.

The natural course of HCV infection and the need for treatment.

Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.

P304

2793-2798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I18.2793

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Tommaso Stroffolini

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236921745

http://www.w3.org/2001/XMLSchema#string

P698

23687416

http://www.w3.org/2001/XMLSchema#string

P921

P932

3653153

http://www.w3.org/2001/XMLSchema#string